🔎 Trials Near Me

Home › High Blood Pressure › NCT04832009

Reversing Glucose and Lipid-mediated Vascular Dysfunction

RecruitingEarly phase 1Healthy volunteers welcome

Reversing Glucose and Lipid-mediated Vascular Dysfunction (REGAL)

Who can join

Ages 18 to 79 · All sexes · Healthy volunteers welcome

Full eligibility criteria
Inclusion Criteria:

* Lean: BMI \< 25 kg/m
* Normal insulin sensitivity: (calculation based on fasting glucose and insulin concentrations in blood)
* Middle-aged: 18-79 years
* Blood pressure: \< 140 (systolic) and \< 90 mmHg (diastolic
* Weight stable (+/- 5 lbs) for the previous 3 months
* Participants must be willing and able to discontinue taking any vitamin C or E supplements or omega-3 fatty acids beginning 2 weeks prior.
* Able and willing to provide written informed consent

Exclusion Criteria:

* Diabetes mellitus Type I or Type II: fasting glucose \< 126 mg/dL and/or HbA1c \< 6.5%
* Current smoker or History of smoking in the past 3 months.
* Hyperlipidemia: Fasting triglycerides \< 250 mg/dL
* Hypertension: \>130/80 mmHg
* History of heart disease (e.g., myocardial infarction, stent, heart attack, stroke, heart failure, valvular heart disease, cardiomyopathy)
* History of vascular disease (e.g., bypass, stroke)

About the study

The purpose of our study is to understand the extent to which the blood vessels are affected by glucose and fat (lipids) in lean healthy adults and if these changes in the blood vessels contribute to the development of high blood pressure.

What is being tested

Sponsor: University of Kansas Medical Center · Participants: 46 · Started: May 9, 2022

Contact the study team

Official record on ClinicalTrials.gov — NCT04832009

Locations in the U.S.

KansasUniversity of Kansas Medical Center, Kansas City

Conditions

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.